Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 13 - Number 1





The Effect of Lead Exposure on Selected Blood Inflammatory Biomarkers in Guinea pigs

, 13(1): 45 - 49

Tahere Farkhondeh, Mohammad Hossein Boskabady, Mohammd Kazem Koohi, Goudarz Sadeghi-Hashjin and Mostafa Moin


DOI: 10.2174/1871529X11313010005


Fc-independent Phagocytosis: Implications for IVIG and other Therapies in Immune-mediated Thrombocytopenia

, 13(1): 50 - 58

June Li, Dianne E. van der Wal, Lingyan Zhu, Brian Vadasz, Elisa K. Simpson, Conglei Li, Michelle Lee Webster, Guangheng Zhu, Sean Lang, Pingguo Chen, Qingshu Zeng and Heyu Ni


DOI: 10.2174/1871529X11313010006






Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography
View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog